WINNIPEG, CANADA, Marketwire, December 16, 2010.

CCSVI Clinic Physicians (www.ccsviclinic.ca) have applied for an International ethics board study approval that will
allow them to use the data on patients where their new treatment

protocol is being studied. Dr. Anand Alurkar, the Interventional

Neurosurgeon at Noble Hospital has done thousands of Intra and Extra

cranial angio-procedures over the past 10 years. His studies indicate

that it’s critical to position and movement control patients who have

had venous angioplasty post-procedure, monitor them for days afterward

with various imaging techniques, for other symptoms, and re-treat if

necessary. CCSVI Clinic is already sponsoring patients for this protocol

with a 10-day stay in the hospital where patients will be imaged daily,

post procedure. If there is evidence of re-occlusion, they will be

taken back to the OR and re-treated. Dr. Alurkar’s past studies of

non-MS patients with the same venous blockages have noted a cascade of

failure points distally in venous vessels post angioplasty, and he would

expect that the study with MS patients will produce the same results.

His normal treatment regime includes a protocol which includes a high

concentration on post-procedure aftercare and follow-up. To comply with

the ethics board approval, once home, patients will be examined and

interviewed at regular intervals by CCSVI Clinic Physician

Researchers for several years after the treatment to study the changes.

More and more MS patients are reporting initial success (including vascular and some neurological differences) as a result of the venous
angioplasty (liberation therapy) but then regression to previous

symptoms sometimes within weeks post-procedure. It is estimated that the

failure rate of the “liberation therapy” may be 50% or higher, even

through the most experienced and best-known surgeons in Poland and

Albany, NY. Consequently, there is increasing concern amongst patients

that the procedure hypothesis needs to include a post-procedure protocol

that is more effective than simply releasing the patient from the

hospital or clinic within hours or a day of the procedure. Dr. Alurkar’s

previous studies reveal there are many other considerations

that indicate a stabilization period, re-examination, and re-treatment

if necessary. Where protocol is followed, the current results have been

consistently high enough to confirm Alurkar’s hypothesis.

Furthermore, it’s the universal feeling of the physicians and researchers at Noble Hospital, who are in a research partnership with
CCSVI Clinic, (with offices and research associates in Winnipeg, Toronto

and Atlanta) that many corners are being cut by all big clinics

performing the procedure to take advantage of the over-whelming

world-wide demand for treatment in an opportunistic approach that

focuses on hospital revenue. It is also possible that these physicians,

besides being drawn to the financial benefits of the procedure, are

unaware of the post-procedure hypothesis put forward by Dr. Alurkar for

his non-MS patient population studies.

Noble Hospital and CCSVI Clinic are expecting ethics board approval for their study within 30 days and results will be released on an
ongoing basis given the already high interest in the findings. The goal

with this study is to provide a prospective look at patients undergoing

the “liberation therapy” with the extended post-procedure protocol and

compare it to patients who receive minimal post-procedure surveillance.

Regular research updates will be published on the CCSVI Clinic website. Questions may be directed toward the CCSVI
Clinic administration at 1-888-419-6855. Persons wishing to book a

procedure should call the same number but should recognize that they

must participate in the study and will be followed for several years by

the study research team. Interested persons should ensure that

applications are in as soon as possible since there are limitations on

the study population.

http://ccsviclinic.ca/?p=765